A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

A new research paper was published in Aging (Aging-US) on January 31, 2025, in Volume 17, Issue 2, titled "Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic ...

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...

Overall, Cysltr1 is a promising target for modulating the impact of aging on retinal tissue."BUFFALO, NY — March 25, 2025 — A new research paper was ...

EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & ...

Researchers have developed a groundbreaking eye drop treatment that slows vision loss in animal models of retinitis ...

Hubble Therapeutics LLC a patient-focused biotechnology company developing a gene therapy to cure pediatric blindness, announces the successful ...

We recently published a list of 11 Best Extremely Profitable Stocks to Buy According to Analysts. In this article, we are ...

Researchers at Penn Vet and the University of Padova identified a novel variant connected to progressive retinal atrophy ...